Overcoming     Patient Recruitment Issues in                                                                      Clinical...
About the Evolution Summit 2012  The      Pharma        Network          -  marcus evans Summits group                    ...
Upcoming SlideShare
Loading in …5
×

Overcoming Patient Recruitment Issues in Clinical Trials - Jeffrey Litwin, ERT

844 views

Published on

Jeffrey Litwin, M.D. of ERT, a solution provider company at the marcus evans Evolution Summit 2012, on better patient recruitment in clinical trials.
Interview with: Jeffrey Litwin, M.D. Chief Executive Officer, ERT


Published in: Business
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
844
On SlideShare
0
From Embeds
0
Number of Embeds
1
Actions
Shares
0
Downloads
11
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Overcoming Patient Recruitment Issues in Clinical Trials - Jeffrey Litwin, ERT

  1. 1. Overcoming Patient Recruitment Issues in Clinical Trials otherwise be eligible. Criteria are often to ensure that patients have adequate copied from another study and new information on both the benefits and exclusion criteria for that particular risks of medications. The centralized drug are added. Some of the collection of data would contribute to exclusions that carry over from one better safety databases. drug to another are inappropriate. What often happens is a study starts What could CMOs take advantage and the CMO finds that many people of today, to enhance or nurture were excluded for an inapplicable innovation in this field? reason. Re-writing the protocol ends up being costly and time consuming. They have to look at the big picture, how the drug or drug development What is missing in clinical program fits into what is currentlyInterview with: Jeffrey Litwin, M.D. development today? available in the marketplace and howChief Executive Officer, ERT they can create a marketing or labeling Companies are not sharing their data. differentiation. What innovation is the Many are working on similar drug bringing to the marketplace?“Pharmaceutical companies can have compounds, when others have alreadymore success in drug development if found that they do not work. There arethey recruit enough of the right few publications of failed studies.patients into their clinical trials,” says Pharmaceutical companies considerDr. Jeffrey Litwin, Chief Executive this information as a competitiveOfficer, ERT. More time must be spenton the inclusion and exclusion criteria,so that eligible patients are not advantage, but the reality is that the industry is spending billions of dollars on drugs that have proven Re-writingunnecessarily excluded, he adds. unsuccessful. Also, if a certain compound has failed, it does not mean the protocol ends upFrom a solution provider company at that it would not succeed in a betterthe upcoming marcus evans designed study or in a differentE v o l u ti o n Su m m i t 2012 , in formulation. At least other scientistsWheeling, Illinois, April 30 - May 2,Litwin offers his expertise intoimproving patient recruitment, clinical would have some data to work from. Large pharmaceutical companies would all benefit by sharing information on being costlytrial success and innovation. their failures as much as their successes. and timeWhat could improve the successrate of clinical trials? What should they focus more of their time on? consumingChief Medical Officers (CMOs) haveto make sure that protocols are well Everyone is focused on drug efficacywritten, so that the inclusion and and labeling. Of course drug approvalexclusion criteria do not eliminate a is based on that data, but drug safetylarge number of patients who would and pharmacovigilance are important
  2. 2. About the Evolution Summit 2012 The Pharma Network - marcus evans Summits group This unique forum will take place at the Westin Chicago North Shore, Wheeling, delivers peer-to-peer information Illinois, April 30 - May 2, 2012. Offering much more than any conference, exhibition on strategic matters, professional or trade show, this exclusive meeting will bring together esteemed industry thought trends and breakthrough leaders and solution providers to a highly focused and interactive networking event. innovations. The Summit includes presentations on the future of drug development, developing a culture of safety and maximizing return on investment. www.evolutionsummit.com Please note that the Summit is a Contact closed business event and the number of participants strictly Sarin Kouyoumdjian-Gurunlian, Press Manager, marcus evans, Summits limited. Division Tel: + 357 22 849 313 Email: press@marcusevanscy.com For more information please send an email to info@marcusevanscy.com All rights reserved. The above content may be republished or reproduced. Kindly inform us by sending an email to press@marcusevanscy.comAbout ERTERT (www.ert.com) is a global technology-driven provider of health outcomes research services and customizable medicaldevices supporting biopharmaceutical sponsors and Contract Research Organizations (CROs) to achieve their drug developmentand healthcare objectives. ERT harnesses leading technology coupled with unrivaled processes and scientific expertise to collect,analyze, and report on clinical data to support the determination of health outcomes critical to the approval, labeling andreimbursement of pharmaceutical products. ERT is the acknowledged industry leader in centralized cardiac safety and respiratoryefficacy services and also provides electronic Patient Reported Outcomes (ePRO) and Outcomes Assessments for multiplemodalities across all phases.For more information: www.ert.comAbout marcus evans Summitsmarcus evans Summits are high level business forums for the world’s leading decision-makers to meet, learn and discussstrategies and solutions. Held at exclusive locations around the world, these events provide attendees with a unique opportunity toindividually tailor their schedules of keynote presentations, think tanks, seminars and one-on-one business meetings.For more information, please visit: www.marcusevans.comUpcoming EventsDiscovery Summit (Europe) - www.discovery-summit.comDiscovery Summit (North America) - www.thediscoverysummit.comEvolution Summit (Europe) - www.evolution-summit.comTo view the web version of this interview please click here: www.evolutionsummit.com/JeffreyLitwin

×